Abstract
SummaryThe serum levels of seromucoid were examined in patients with a wide variety of benign and malignant gynaecological disorders. Seromucoid was unchanged from normal in most benign conditions, but it was raised in pelvic infection and tended to be low in infertility. Serum seromucoid was unchanged in patients with carcinoma in situ, but was increased substantially above normal with invasive cancer. The level of serum seromucoid in patients with cancer was related to the severity of the clinical lesion and returned to normal when the lesion was successfully treated. Cases of recurrent carcinoma had highly elevated serum seromucoid levels. The measurement of serum seromucoid levels may be a useful means of assessing the severity of cancer and monitoring the effectiveness of its treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: BJOG: An International Journal of Obstetrics & Gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
